Ticker brief
SILO
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
4
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-06-29 · now +0.25 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AlertsAndNews | C | +1.52 | 2 | +0.35 |
| @OzmosiHealth | C | · | 2 | +0.28 |
| @BearaBullBella | C | +0.10 | 1 | +0.00 |
| @CrweWorld | C | · | 1 | +0.20 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-29 | @CrweWorld | +0.20 | Silo advances SPC-15 study ahead of planned FDA Type C meeting request. | · | tweet ↗ |
| 2026-06-29 | @OzmosiHealth | +0.25 | Silo advances SPC-15 with robustness study before planned FDA Type C meeting request. | · | tweet ↗ |
| 2026-06-29 | @AlertsAndNews | +0.30 | Silo Pharma advances SPC-15 PTSD therapeutic study ahead of planned FDA Type C meeting request. | · | tweet ↗ |
| 2026-06-23 | @OzmosiHealth | +0.30 | Silo reports positive stability data for SPC-15, advancing toward first-in-human trial. | · | tweet ↗ |
| 2026-06-23 | @AlertsAndNews | +0.40 | Silo reports positive stability data for SPC-15 advancing toward first-in-human trial. | · | tweet ↗ |
| 2026-06-22 | @BearaBullBella | +0.00 | Says psychedelics names are halted on news and references SILO, but content of news is unspecified. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.